source
- Pharvaris reports injectable-like efficacy from once-daily oral pill for rare genetic diseasePharvaris announced that its experimental oral formulation of deucrictibant achieved efficacy comparable to injectable versions in a once-daily pill. The drug is an extended-release version intend…
- Sanofi presents detailed asthma trial data while AstraZeneca reports positive COPD results at ERS 2026At the European Respiratory Society meeting in Barcelona, Sanofi disclosed detailed findings from its asthma trial, building on earlier indications of efficacy. The data highlighted specific endpo…